ChenGuang Biotech Group Co., Ltd.

SZSE:300138 Stock Report

Market Cap: CN¥4.3b

ChenGuang Biotech Group Balance Sheet Health

Financial Health criteria checks 3/6

ChenGuang Biotech Group has a total shareholder equity of CN¥3.1B and total debt of CN¥4.0B, which brings its debt-to-equity ratio to 129.8%. Its total assets and total liabilities are CN¥7.7B and CN¥4.6B respectively. ChenGuang Biotech Group's EBIT is CN¥311.5M making its interest coverage ratio 4.9. It has cash and short-term investments of CN¥2.6B.

Key information

129.8%

Debt to equity ratio

CN¥4.04b

Debt

Interest coverage ratio4.9x
CashCN¥2.55b
EquityCN¥3.11b
Total liabilitiesCN¥4.64b
Total assetsCN¥7.75b

Recent financial health updates

No updates

Recent updates

A Piece Of The Puzzle Missing From ChenGuang Biotech Group Co., Ltd.'s (SZSE:300138) 43% Share Price Climb

Oct 08
A Piece Of The Puzzle Missing From ChenGuang Biotech Group Co., Ltd.'s (SZSE:300138) 43% Share Price Climb

ChenGuang Biotech Group (SZSE:300138) Might Be Having Difficulty Using Its Capital Effectively

Sep 30
ChenGuang Biotech Group (SZSE:300138) Might Be Having Difficulty Using Its Capital Effectively

Return Trends At ChenGuang Biotech Group (SZSE:300138) Aren't Appealing

May 13
Return Trends At ChenGuang Biotech Group (SZSE:300138) Aren't Appealing

Impressive Earnings May Not Tell The Whole Story For ChenGuang Biotech Group (SZSE:300138)

Apr 25
Impressive Earnings May Not Tell The Whole Story For ChenGuang Biotech Group (SZSE:300138)

ChenGuang Biotech Group Co., Ltd. (SZSE:300138) Just Reported, And Analysts Assigned A CN¥17.66 Price Target

Apr 21
ChenGuang Biotech Group Co., Ltd. (SZSE:300138) Just Reported, And Analysts Assigned A CN¥17.66 Price Target

Financial Position Analysis

Short Term Liabilities: 300138's short term assets (CN¥5.6B) exceed its short term liabilities (CN¥3.1B).

Long Term Liabilities: 300138's short term assets (CN¥5.6B) exceed its long term liabilities (CN¥1.5B).


Debt to Equity History and Analysis

Debt Level: 300138's net debt to equity ratio (47.7%) is considered high.

Reducing Debt: 300138's debt to equity ratio has increased from 65.7% to 129.8% over the past 5 years.

Debt Coverage: 300138's debt is not well covered by operating cash flow (0.8%).

Interest Coverage: 300138's interest payments on its debt are well covered by EBIT (4.9x coverage).


Balance Sheet


Discover healthy companies